Advarra – formed recently following the merger of Chesapeake IRB and Schulman IRB – provides institutional review board (IRB), institutional biosafety committee (IBC), and global research compliance services.
TransPerfect has been a long-standing partner of both IRBs prior to the merger, Jeff Wendel, Advarra president told Outsourcing-Pharma.com.
"TransPerfect uses the translation memory we’ve built over years of working together to continuously improve translation turnaround times while maintaining high levels of accuracy and quality," Wendel explained.
"Its TransPort platform provides our staff with transparency into the process, helping us to streamline our internal workflows to meet client timelines," he added.
TransPerfect also recently announced that ARCA Biopharma selected its Trial Interactive eTMF solution as its enterprise platform for clinical trials.
The CO-based biopharmaceutical company used the solution to support a Phase II trial across 50 sites, and moving forward, will transfer all trials to a paperless environment.